INCYTE
About the organisation
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of various therapeutics in the United States. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; and Iclusig, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia. You have been given clear instructions, reach out to us before it's too late.
What the listing means
INCYTE appeared on the dragonforce leak site on 22 April 2026. Groups publish a victim once negotiations stall or as pressure during them, so a listing usually means data was already exfiltrated — the attack itself is dated 21 April 2026, 1 day before the listing. This group has published 39 claims in the last 30 days and remains active.
Recommended actions
- Treat any unsolicited message referencing INCYTE as suspicious — leaked data gets weaponised for phishing within days.
- If you hold an account on www.incyte.com, change that password now, update it anywhere you reused it, and enable two-factor authentication.
- Other Healthcare organisations should review this group's known TTPs and validate detection coverage against them.
- Watch for follow-on extortion: stolen data is often re-leaked or resold after the initial listing.
- A leak-site listing is a claim made by the attacker, not a confirmed breach — check the organisation's own disclosures before acting on it.
Leak-site evidence
Listing URL https://www.ransomware.live/id/SU5DWVRFQGRyYWdvbmZvcmNl
Show leak-site screenshot
Captured from the group's extortion site. It may contain the victim's data or the attacker's messaging.
